Skip to main content

Intensity Therapeutics, Inc 10-Q for FY2025 Q2

Intensity Therapeutics, Inc. (INTS)

10-Q 2025-08-07 For: 2025-06-30
View Original
Added on April 06, 2026

About this 10-Q

Intensity Therapeutics, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$2.54M
compared with a net loss of $4.97M a year earlier
Diluted EPS
-$0.13
compared with -$0.36 a year earlier